CB Insights
Technology Market Intelligence
Technology Market Intelligence
SanBio is a regenerative medicine company with cell-based products in various stages of research, development, and clinical trials. Its proprietary cell-based product, SB623, was built for treatment of chronic motor impairments resulting from stroke.
Company (Alive / Active)
Phone:
St. Luke Tower 28F
8-1 Akashi-cho, Chuo-ku
Tokyo, 104-0044
Japan
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Methods and compositions for treatment of retinal degeneration | Mar 21, 2016 | Jan 02, 2018 | Patent |
| Methods and compositions for treatment of traumatic brain injury and for modulation of migration of neurogenic cells | Mar 13, 2013 | Nov 28, 2017 | Patent |
| Methods and compositions for modulating peripheral immune function | Jun 06, 2014 | May 23, 2017 | Patent |
| Methods and compositions for modulating peripheral immune function | Oct 02, 2015 | May 02, 2017 | Patent |
| Cells exhibiting neuronal progenitor cell characteristics and methods of making them | Jun 09, 2015 | Sep 13, 2016 | Patent |
